4.8 Article

XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia

Journal

NATURE
Volume 541, Issue 7635, Pages 87-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature20790

Keywords

-

Funding

  1. MRC [MR/J006750/1, MR/P010121/1]
  2. CAPES Foundation, Ministry of Education, Brazil [BEX9769-13-7]
  3. Genome Canada
  4. Canadian Institutes of Health Research
  5. Ontario Genomics Institute
  6. Ontario Research Fund
  7. Genome Quebec
  8. Children's Hospital of Eastern Ontario Foundation
  9. Hospital for Sick Children
  10. BBSRC [BB/K019015/1]
  11. National Institutes of Health [NS-37956, CA-21765]
  12. CCSG [P30 CA21765]
  13. American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital
  14. BBSRC [BB/K019015/1] Funding Source: UKRI
  15. MRC [MR/P010121/1, MR/J006750/1] Funding Source: UKRI
  16. Biotechnology and Biological Sciences Research Council [BB/K019015/1] Funding Source: researchfish
  17. Cancer Research UK [16771] Funding Source: researchfish
  18. Medical Research Council [MR/P010121/1, MR/J006750/1] Funding Source: researchfish

Ask authors/readers for more resources

XRCC1 is a molecular scaffold protein that assembles multiprotein complexes involved in DNA single-strand break repair(1,2). Here we show that biallelic mutations in the human XRCC1 gene are associated with ocular motor apraxia, axonal neuropathy, and progressive cerebellar ataxia. Cells from a patient with mutations in XRCC1 exhibited not only reduced rates of single-strand break repair but also elevated levels of protein ADP-ribosylation. This latter phenotype is recapitulated in a related syndrome caused by mutations in the XRCC1 partner protein PNKP3-5 and implicates hyperactivation of poly(ADP-ribose) polymerase/s as a cause of cerebellar ataxia. Indeed, remarkably, genetic deletion of Parp1 rescued normal cerebellar ADP-ribose levels and reduced the loss of cerebellar neurons and ataxia in Xrcc1-defective mice, identifying a molecular mechanism by which endogenous single-strand breaks trigger neuropathology. Collectively, these data establish the importance of XRCC1 protein complexes for normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available